Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

Articles published in
J Cardiol
    September 2025
  1. SINGH YS, Matsue Y, Iso T, Fujimoto Y, et al
    Daprodustat for patients with heart failure and renal Anemia: A pilot multicenter, open-label, randomized controlled study.
    J Cardiol. 2025 Sep 18:S0914-5087(25)00241-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  2. OKADA M, Inoue K, Onishi T, Tanaka N, et al
    Cardiothoracic Ratio as a Prognostic Marker in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2025 Sep 14:S0914-5087(25)00238-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  3. PENG JR, Chen TH, Chen DY, Lin Y, et al
    SGLT2i with ARNi versus RASi in Heart Failure with Reduced Ejection Fraction: Improved Survival and Reduced Hyperkalemia Risk in a Real-World Cohort Study.
    J Cardiol. 2025 Sep 10:S0914-5087(25)00225-4. doi: 10.1016/j.jjcc.2025.
    >> Share

  4. MORI Y, Natori S, Arai T, Kakuya F, et al
    Biomarker-based pre-heart failure screening in a middle-aged rural population.
    J Cardiol. 2025 Sep 4:S0914-5087(25)00223-0. doi: 10.1016/j.jjcc.2025.
    >> Share

    August 2025
  5. FUJIMOTO N, Omori T, Moriwaki K, Nakamori S, et al
    Pressure-volume loop analysis in heart failure with preserved ejection fraction: Implications for cardiac mechanics, diagnosis, and treatment strategy.
    J Cardiol. 2025 Aug 28:S0914-5087(25)00215-1. doi: 10.1016/j.jjcc.2025.
    >> Share

  6. LUO S
    Letter to the editor: Impact of congestive heart failure on early fluid administration and mortality in patients with sepsis.
    J Cardiol. 2025 Aug 26:S0914-5087(25)00214-X. doi: 10.1016/j.jjcc.2025.
    >> Share

  7. FUJIMOTO Y, Kitai T, Horiuchi Y, Kondo T, et al
    Chronic kidney disease and contemporary guideline-directed medical therapy during hospitalization in patients with heart failure: Insights from PRE-UPFRONT-HF.
    J Cardiol. 2025 Aug 21:S0914-5087(25)00211-4. doi: 10.1016/j.jjcc.2025.
    >> Share

  8. OZAKI Y, Uemura Y, Kondo T, Kazama S, et al
    Hemodynamic integration of pulmonary artery pulsatility index and compliance for risk stratification in patients with heart failure with reduced ejection fraction.
    J Cardiol. 2025 Aug 6:S0914-5087(25)00204-7. doi: 10.1016/j.jjcc.2025.
    >> Share

  9. FUJIMOTO W, Matsumoto S, Kanaoka K, Nasu T, et al
    Implications of asymptomatic hypotension for patients prescribed sacubitril/valsartan: Insight from the REVIEW-HF registry.
    J Cardiol. 2025;86:202-208.
    >> Share

    July 2025
  10. NAGAI S, Kondo T, Morimoto R, Hiraiwa H, et al
    Association of Trace Element Abnormalities and Adverse Outcomes in Patients with Acute Heart Failure.
    J Cardiol. 2025 Jul 25:S0914-5087(25)00193-5. doi: 10.1016/j.jjcc.2025.
    >> Share

  11. ARASAKI Y, Toma Y, Minei A, Hirata T, et al
    Association of hospitalization-associated disability and all-cause mortality or hospitalizations for heart failure in elderly patients undergoing transcatheter aortic valve replacement.
    J Cardiol. 2025 Jul 12:S0914-5087(25)00186-8. doi: 10.1016/j.jjcc.2025.
    >> Share

  12. MA Z, Krishnamurthy M, Yellapu V, Amaratunga E, et al
    Impact of congestive heart failure on early fluid administration and mortality in patients with sepsis.
    J Cardiol. 2025 Jul 11:S0914-5087(25)00185-6. doi: 10.1016/j.jjcc.2025.
    >> Share

  13. FUJIMOTO Y, Kitai T, Nasu T, Matsumoto S, et al
    Diuretic resistance measured by sodium excretion and urine output in acute heart failure: The DIURESIS-AHF study.
    J Cardiol. 2025 Jul 2:S0914-5087(25)00171-6. doi: 10.1016/j.jjcc.2025.
    >> Share

  14. KOLOKATHIS K, Doundoulakis I, Tsiachris D, Kordalis A, et al
    Efficacy and safety of leadless cardiac resynchronization therapy: An updated meta-analysis.
    J Cardiol. 2025;86:93-94.
    >> Share

    June 2025
  15. CALCAGNO T, Issa R, Massad F, Kaelber D, et al
    Finerenone and cardiovascular outcomes in heart failure with mildly reduced and preserved ejection fraction: A propensity-matched analysis.
    J Cardiol. 2025 Jun 29:S0914-5087(25)00166-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  16. POPAT A, Yadav S, Pethe G, Rehman A, et al
    The role of POCUS in diagnosing acute heart failure in the emergency department: A Meta-analysis.
    J Cardiol. 2025 Jun 22:S0914-5087(25)00165-0. doi: 10.1016/j.jjcc.2025.
    >> Share

  17. TANG J, Bolourchi A, Ahmad M
    This letter refers to "association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A nationwide propensity score-matched study" by Isogai et al., journal of cardiology 2025;85:220-8.
    J Cardiol. 2025 Jun 19:S0914-5087(25)00161-3. doi: 10.1016/j.jjcc.2025.
    >> Share

  18. ARITA J, Ohishi T, Sasajima T, Yarimizu D, et al
    Real-world safety of Sacubitril/valsartan in Japanese patients with chronic heart failure: a post-marketing surveillance study.
    J Cardiol. 2025 Jun 2:S0914-5087(25)00144-3. doi: 10.1016/j.jjcc.2025.
    >> Share

    May 2025
  19. UCHIDA S, Kamiya K, Yamashita M, Noda T, et al
    Current findings and challenges on frailty, sarcopenia, and Cachexia in older patients with heart failure: insights from the FRAGILE-HF study.
    J Cardiol. 2025 May 28:S0914-5087(25)00138-8. doi: 10.1016/j.jjcc.2025.
    >> Share

  20. ENZAN N, Tohyama T, Watanabe T, Nagata T, et al
    Clinical characteristics and outcomes of hospitalized patients with heart failure from the Japanese prospective registry.
    J Cardiol. 2025 May 27:S0914-5087(25)00139-X. doi: 10.1016/j.jjcc.2025.
    >> Share

  21. MARCHETTA M, Parato AG, Vizzari G, Chiricolo G, et al
    Effects of early initiation of mineralocorticoid receptor antagonist therapy in acute decompensated heart failure: a systematic review and meta-analysis.
    J Cardiol. 2025 May 22:S0914-5087(25)00129-7. doi: 10.1016/j.jjcc.2025.
    >> Share

  22. EGAMI Y, Kobayashi N, Sugino A, Abe M, et al
    Impact of Sinus Rhythm Maintenance After Repeat Catheter Ablation on Clinical Outcomes in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2025 May 20:S0914-5087(25)00127-3. doi: 10.1016/j.jjcc.2025.
    >> Share

  23. SHIRAKABE A, Matsushita M, Shigihara S, Nishigoori S, et al
    Age-specific differences of Impella support in Japanese patients: The Japanese Registry for Percutaneous Ventricular Assist Device (J-PVAD) registry analysis on outcomes and adverse events.
    J Cardiol. 2025;85:343-351.
    >> Share

  24. VOLK MC, Mirzai S, Persits I, Sarnaik KS, et al
    Associations of adipose tissue depots with cardiac resynchronization therapy response and clinical outcomes: A CRT-HF Clinic substudy.
    J Cardiol. 2025;85:421-423.
    >> Share

    April 2025
  25. SHIMOYA Y, Tani Y, Yuasa N, Kagami K, et al
    Pathophysiologic and prognostic relevance of mid-upper arm circumference index in heart failure with preserved ejection fraction.
    J Cardiol. 2025 Apr 28:S0914-5087(25)00107-8. doi: 10.1016/j.jjcc.2025.
    >> Share

  26. IBRAHIM M
    Letter to the editor on association between complementary use of Goreisan and heart failure readmission: A nationwide propensity score-matched study.
    J Cardiol. 2025 Apr 24:S0914-5087(25)00104-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  27. SAITO Y, Kagiyama N, Harada T, Kaneko T, et al
    An evidence-based tool for screening for heart failure with preserved ejection fraction in primary care: The BREATH(2) score.
    J Cardiol. 2025 Apr 3:S0914-5087(25)00098-X. doi: 10.1016/j.jjcc.2025.
    >> Share

  28. NISHINARITA R, Oikawa J, Arao K, Sugisaki K, et al
    Prognosis of low-flow low-gradient aortic valve stenosis with atrial fibrillation.
    J Cardiol. 2025 Apr 2:S0914-5087(25)00097-8. doi: 10.1016/j.jjcc.2025.
    >> Share

    March 2025
  29. OKAJIMA T, Ishikawa S, Uemura Y, Ozaki Y, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors on preventing atrial arrhythmia recurrences after atrial fibrillation ablation in patients with heart failure.
    J Cardiol. 2025 Mar 19:S0914-5087(25)00088-7. doi: 10.1016/j.jjcc.2025.
    >> Share

  30. TSUCHIDA K, Tanabe N, Tanaka K, Ozeki K, et al
    Twelve-year trends of hospitalizations and survival of acute decompensated heart failure: Data from a regional tertiary center.
    J Cardiol. 2025 Mar 19:S0914-5087(25)00089-9. doi: 10.1016/j.jjcc.2025.
    >> Share

  31. YAMAMOTO A, Nagao M, Nomoto M, Inoue A, et al
    Prediction of cardiac allograft vasculopathy using splenic switch-off on myocardial PET.
    J Cardiol. 2025;85:260-262.
    >> Share

    February 2025
  32. LI M, Zhang J, Hu Y, Zhang Y, et al
    Cognitive impairment in patients with heart failure: Physiopathology, clinical implications, and therapeutic considerations.
    J Cardiol. 2025 Feb 12:S0914-5087(25)00056-5. doi: 10.1016/j.jjcc.2025.
    >> Share

  33. HOSODA Y, Goda A, Yanagisawa Y, Miura Y, et al
    Prediction of left ventricular reverse remodeling in patients with heart failure with reduced ejection fraction using cardiopulmonary exercise testing.
    J Cardiol. 2025 Feb 5:S0914-5087(25)00021-8. doi: 10.1016/j.jjcc.2025.
    >> Share

  34. SIDDIQI AK, Shahzad M, Kumar A, Ahmed M, et al
    The efficacy of inspiratory muscle training in improving clinical outcomes in heart failure patients: An updated systematic review and Meta-analysis.
    J Cardiol. 2025 Feb 3:S0914-5087(25)00016-4. doi: 10.1016/j.jjcc.2025.
    >> Share

  35. HAMAGUCHI K, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Comparison of clinical outcomes between proximal and non-proximal right coronary artery occlusion in patients with inferior ST-segment elevation myocardial infarction.
    J Cardiol. 2025;85:88-95.
    >> Share

    January 2025
  36. BASILE P, Guaricci AI
    Author's reply to the Letter to the Editor "How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts".
    J Cardiol. 2025 Jan 31:S0914-5087(25)00012-7. doi: 10.1016/j.jjcc.2025.
    >> Share

  37. HORIUCHI Y, Matsue Y, Wettersten N, Oishi S, et al
    Racial differences in diuretic therapy, B-type natriuretic peptide values, and prognosis in acute heart failure.
    J Cardiol. 2025 Jan 30:S0914-5087(25)00013-9. doi: 10.1016/j.jjcc.2025.
    >> Share

  38. AKAMA Y, Matsue Y, Maeda D, Dotare T, et al
    Prognostic values of proteinuria in patients with acute heart failure.
    J Cardiol. 2025 Jan 28:S0914-5087(25)00010-3. doi: 10.1016/j.jjcc.2025.
    >> Share

  39. KATAOKA N, Imamura T
    How to demonstrate the causal relationship between sodium-glucose cotransporter 2 receptor and prevention of ventricular arrhythmia in heart failure cohorts.
    J Cardiol. 2025 Jan 20:S0914-5087(25)00006-1. doi: 10.1016/j.jjcc.2025.
    >> Share

  40. YUASA N, Ubukata S, Takayanagi R, Yamashita E, et al
    Collaboration between dyspnea clinic and primary care physicians to identify heart failure with preserved ejection fraction in the community: Results from the Maebashi City HF project.
    J Cardiol. 2025 Jan 14:S0914-5087(25)00001-2. doi: 10.1016/j.jjcc.2025.
    >> Share

  41. PASCOE MA, Kolodziej A, Birks EJ, Vaidya G, et al
    Using electronic medical records to identify patients at risk for underlying cardiac amyloidosis.
    J Cardiol. 2025;85:43-44.
    >> Share

    December 2024
  42. SUZUKI Y, Kaneko H, Okada A, Fujiu K, et al
    BP classification using the 2017 ACC/AHA BP guidelines with risk of cardiovascular events in older individuals.
    J Cardiol. 2024;84:394-403.
    >> Share

    November 2024
  43. RAJAKUMAR HK
    Telemonitoring in heart failure care: Does feasibility equate to clinical benefit?
    J Cardiol. 2024 Nov 26:S0914-5087(24)00219-3. doi: 10.1016/j.jjcc.2024.
    >> Share

  44. RMILAH AA, Abdelhafez M, Balla AK, Ahmad S, et al
    Outcomes of mitral TEER in non-responders to cardiac resynchronization therapy: A systematic review and meta-analysis.
    J Cardiol. 2024;84:317-325.
    >> Share

  45. ONODA H, Imamura T, Ueno H, Oshima A, et al
    Paradoxical prognostic impact of severe aortic stenosis following trans-catheter aortic valve implantation.
    J Cardiol. 2024;84:311-316.
    >> Share

    October 2024
  46. KOMURO J, Kaneko H, Suzuki Y, Okada A, et al
    Unawareness of being prescribed medications for diabetes and incident cardiovascular disease.
    J Cardiol. 2024;84:294-299.
    >> Share

  47. MIYAKE M, Izumi C, Watanabe H, Ozasa N, et al
    Prognostic value of E/e' ratio and its change over time in ST-segment elevation myocardial infarction with preserved left ventricular ejection fraction in the reperfusion era.
    J Cardiol. 2024;84:253-259.
    >> Share

    September 2024
  48. ISOGAI T, Morita K, Okada A, Michihata N, et al
    Association between complementary use of Goreisan (a Japanese herbal Kampo medicine) and heart failure readmission: A Nationwide propensity score-matched study.
    J Cardiol. 2024 Sep 26:S0914-5087(24)00182-5. doi: 10.1016/j.jjcc.2024.
    >> Share

  49. SUETA D, Araki S, Usuku H, Fujisaki T, et al
    Clinical outcomes of patients from older community hospitalized for heart failure in guideline-directed medical therapy era: Insights from the COMPASS-HF registry.
    J Cardiol. 2024 Sep 17:S0914-5087(24)00178-3. doi: 10.1016/j.jjcc.2024.
    >> Share

  50. TSUTSUI H, Momomura SI, Saito Y, Ito H, et al
    Incidence and risk factors of hypotension-related adverse events among Japanese patients with heart failure receiving sacubitril/valsartan or enalapril: Results from the PARALLEL-HF study.
    J Cardiol. 2024 Sep 14:S0914-5087(24)00174-6. doi: 10.1016/j.jjcc.2024.
    >> Share

  51. BASILE P, Monitillo F, Santoro D, Falco G, et al
    Impact on ventricular arrhythmic burden of SGLT2 inhibitors in patients with chronic heart failure evaluated with cardiac implantable electronic device monitoring.
    J Cardiol. 2024 Sep 13:S0914-5087(24)00177-1. doi: 10.1016/j.jjcc.2024.
    >> Share

  52. MIYAZAKI Y, Ishibashi K, Ueda N, Oka S, et al
    Evaluation of synchronized left ventricular pacing rate over biventricular pacing in cardiac resynchronization therapy.
    J Cardiol. 2024;84:165-169.
    >> Share

    August 2024
  53. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Usefulness of hypochloremia at the time of discharge to predict prognosis in patients with chronic heart failure after hospitalization.
    J Cardiol. 2024 Aug 30:S0914-5087(24)00171-0. doi: 10.1016/j.jjcc.2024.
    >> Share

  54. HASHEM A, Khalouf A, Mohamed MS, Adra S, et al
    Early vs. Late Transcatheter Aortic Valve Replacement in Acute Heart Failure Hospitalizations: A Comparative Nationwide Analysis.
    J Cardiol. 2024 Aug 16:S0914-5087(24)00159-X. doi: 10.1016/j.jjcc.2024.
    >> Share

  55. MATSUMOTO S, McMurray JJV, Nasu T, Ishii S, et al
    Relevant adverse events and drug discontinuation of sacubitril/valsartan in a real-world Japanese cohort: REVIEW-HF registry.
    J Cardiol. 2024;84:133-140.
    >> Share

  56. MATSUSHITA H, Saku K, Nishikawa T, Unoki T, et al
    Impact of right ventricular and pulmonary vascular characteristics on Impella hemodynamic support in biventricular heart failure: A simulation study.
    J Cardiol. 2024 Aug 1:S0914-5087(24)00145-X. doi: 10.1016/j.jjcc.2024.
    >> Share

    July 2024
  57. INOUE K, Smiseth OA
    Left atrium as key player and essential biomarker in heart failure.
    J Cardiol. 2024 Jul 29:S0914-5087(24)00135-7. doi: 10.1016/j.jjcc.2024.
    >> Share


  58. Urinary sodium excretion for loop diuretic response in acute heart failure.
    J Cardiol. 2024 Jul 5:S0914-5087(24)00129-1. doi: 10.1016/j.jjcc.2024.
    >> Share

    June 2024
  59. OKADA T, Takagi W, Miyoshi T, Oka A, et al
    Efficacy and safety of intravenous versus oral tolvaptan in the acute phase of acute decompensated heart failure.
    J Cardiol. 2024 Jun 23:S0914-5087(24)00125-4. doi: 10.1016/j.jjcc.2024.
    >> Share

  60. NODA T, Kamiya K, Hamazaki N, Nozaki K, et al
    Effect of change in hepato-renal function and cardiac rehabilitation on mortality in patients with heart failure.
    J Cardiol. 2024 Jun 23:S0914-5087(24)00123-0. doi: 10.1016/j.jjcc.2024.
    >> Share

  61. HORIUCHI Y, Wettersten N
    Treatment strategies for diuretic resistance in patients with heart failure.
    J Cardiol. 2024 Jun 22:S0914-5087(24)00122-9. doi: 10.1016/j.jjcc.2024.
    >> Share

  62. ITO H, Fujimoto N, Mori H, Kirii Y, et al
    Unveiling the new era of heart failure management using mobile health: A pilot study of "heart sign" focusing on user experience and quality of life.
    J Cardiol. 2024 Jun 11:S0914-5087(24)00103-5. doi: 10.1016/j.jjcc.2024.
    >> Share

  63. SHIBATA T, Mizuno A, Ohmori T, Oishi S, et al
    Public awareness of palliative care for heart failure in Japan: A cross-sectional study.
    J Cardiol. 2024 Jun 3:S0914-5087(24)00101-1. doi: 10.1016/j.jjcc.2024.
    >> Share

  64. SHIINA Y, Nagao M, Itatani K, Shimada E, et al
    4D flow MRI-derived energy loss and RV workload in adults with tetralogy of Fallot.
    J Cardiol. 2024;83:382-389.
    >> Share

    May 2024
  65. VLACHAKIS PK, Tsiachris D, Doundoulakis I, Tsioufis P, et al
    Therapeutic inertia in rhythm control strategies in hospitalized patients with fibrillation: Insights from Hellenic Cardiorenal Morbidity Snapshot (HECMOS) study.
    J Cardiol. 2024;83:313-317.
    >> Share

  66. KAGIYAMA N, Kasai T, Murata N, Yamakawa N, et al
    Feasibility of self-measurement Telemonitoring using a handheld heart sound recorder in patients with heart failure - SELPH multicenter pilot study.
    J Cardiol. 2024 May 1:S0914-5087(24)00082-0. doi: 10.1016/j.jjcc.2024.
    >> Share

    April 2024
  67. BUTTER L, Haase-Fielitz A, Zanker M, Becher G, et al
    Cluster analysis of volatile organic compounds - a pilot study in patients with severe acute decompensated heart failure.
    J Cardiol. 2024 Apr 13:S0914-5087(24)00062-5. doi: 10.1016/j.jjcc.2024.
    >> Share

  68. MAKHOUL GW, Mustafa A, Wei C, Ling J, et al
    Heart failure - An unexplored risk factor for infective endocarditis after pacemaker implantation.
    J Cardiol. 2024 Apr 5:S0914-5087(24)00061-3. doi: 10.1016/j.jjcc.2024.
    >> Share

  69. SAITO S, Okubo S, Matsuoka T, Hirota S, et al
    Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    J Cardiol. 2024;83:228-235.
    >> Share

    March 2024
  70. OHIRA T, Eguchi E, Hayashi F, Kinuta M, et al
    Epidemiology of cardiovascular disease in Japan: An overview study.
    J Cardiol. 2024;83:191-200.
    >> Share

  71. ONODA H, Imamura T, Ueno H, Oshima A, et al
    Prognostic impact of elevated erythropoietin levels in patients with severe aortic stenosis receiving trans-catheter aortic valve implantation.
    J Cardiol. 2024;83:149-154.
    >> Share

    February 2024
  72. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
    Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
    >> Share

  73. YAKU H, Fudim M, Shah SJ
    Role of splanchnic circulation in the pathogenesis of heart failure: State-of-the-art review.
    J Cardiol. 2024 Feb 16:S0914-5087(24)00022-4. doi: 10.1016/j.jjcc.2024.
    >> Share

  74. SHIBATA T, Matsumoto S, Muramoto T, Matsukawa M, et al
    Comparison of the treatment status of patients with acute heart failure before and during the COVID-19 pandemic - Observational cohort study using Japanese administrative data.
    J Cardiol. 2024 Feb 2:S0914-5087(24)00011-X. doi: 10.1016/j.jjcc.2024.
    >> Share

    December 2023
  75. SATO K, Kamiya K, Hamazaki N, Nozaki K, et al
    Association of sarcopenia defined by different skeletal muscle mass measurements with prognosis and quality of life in older patients with heart failure.
    J Cardiol. 2023 Dec 20:S0914-5087(23)00305-2. doi: 10.1016/j.jjcc.2023.
    >> Share

  76. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    >> Share

    November 2023
  77. HEIDENREICH P
    Heart failure management guidelines: New recommendations and implementation.
    J Cardiol. 2023 Nov 8:S0914-5087(23)00271-X. doi: 10.1016/j.jjcc.2023.
    >> Share

    October 2023
  78. UCHIYAMA S, Toki M, Kitai T, Yoshioka K, et al
    Dynamic changes in echocardiographic parameters in acute decompensated heart failure: REALITY-ECHO.
    J Cardiol. 2023 Oct 24:S0914-5087(23)00268-X. doi: 10.1016/j.jjcc.2023.
    >> Share

  79. POL T, Karlstrom P, Lund LH
    Heart failure registries - Future directions.
    J Cardiol. 2023 Oct 14:S0914-5087(23)00257-5. doi: 10.1016/j.jjcc.2023.
    >> Share

  80. SI J, Ding Z, Hu Y, Zhang X, et al
    Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00242-3. doi: 10.1016/j.jjcc.2023.
    >> Share

  81. OKAMURA M, Kataoka Y, Taito S, Fujiwara T, et al
    Early mobilization for acute heart failure: A scoping and a systematic review.
    J Cardiol. 2023 Oct 3:S0914-5087(23)00239-3. doi: 10.1016/j.jjcc.2023.
    >> Share

    September 2023
  82. SEO M, Watanabe T, Yamada T, Morita T, et al
    The clinical relevance of mild cognitive impairment in acute heart failure: A comparison with cognitive impairment.
    J Cardiol. 2023 Sep 6:S0914-5087(23)00222-8. doi: 10.1016/j.jjcc.2023.
    >> Share

  83. MATSUDA H, Kuragaichi T, Sato Y
    Investigating the seasonal variation of heart failure hospitalizations and in-hospital mortality risks in Japan using a nationwide database.
    J Cardiol. 2023 Sep 2:S0914-5087(23)00219-8. doi: 10.1016/j.jjcc.2023.
    >> Share

    August 2023
  84. HORIBE H, Ando K, Maekawa Y, Narisawa M, et al
    The association of serum adiponectin level with activities of daily living in hospitalized elderly patients with heart failure.
    J Cardiol. 2023 Aug 15:S0914-5087(23)00202-2. doi: 10.1016/j.jjcc.2023.
    >> Share

  85. HARRISON NE, Ehrman R, Collins S, Desai AA, et al
    The prognostic value of improving congestion on lung ultrasound during treatment for acute heart failure differs based on patient characteristics at admission.
    J Cardiol. 2023 Aug 12:S0914-5087(23)00190-9. doi: 10.1016/j.jjcc.2023.
    >> Share

  86. ICHIHARA YK, Kohsaka S, Kisanuki M, Sandhu ATS, et al
    Implementation of evidence-based heart failure management: Regional variations between Japan and the USA.
    J Cardiol. 2023 Aug 3:S0914-5087(23)00185-5. doi: 10.1016/j.jjcc.2023.
    >> Share

  87. KLARSKOV VR, Ladefoged BT, Pedersen ALD, Hartig-Andreasen C, et al
    Clinical characteristics and prognostic implications of orthopedic ligament disorders in patients with wild-type transthyretin amyloidosis cardiomyopathy.
    J Cardiol. 2023;82:122-127.
    >> Share

    July 2023
  88. YUASA N, Obokata M, Harada T, Kagami K, et al
    Characterization and Prognostic Importance of Chronotropic Incompetence in Heart Failure with Preserved Ejection Fraction.
    J Cardiol. 2023 Jul 5:S0914-5087(23)00159-4. doi: 10.1016/j.jjcc.2023.
    >> Share

  89. FERREIRA JP, Zannad F, Kiernan MS, Konstam MA, et al
    High- versus low-dose losartan and uric acid: An analysis from HEAAL.
    J Cardiol. 2023;82:57-61.
    >> Share

  90. UGATA Y, Hayashi T, Yamamoto S, Fujita H, et al
    Impact of Q wave in synthesized V7-9 lead on long-term outcomes after cardiac resynchronization therapy.
    J Cardiol. 2023;82:51-56.
    >> Share

  91. MATSUURA K, Kumamaru H, Kohsaka S, Kanda T, et al
    Impact of concomitant mitral regurgitation during transcatheter aortic valve replacement on 1-year survival outcomes.
    J Cardiol. 2023;82:16-21.
    >> Share

  92. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    >> Share

    June 2023
  93. BHATIA K, Sabharwal B, Gupta K, Lopez PD, et al
    Clinical outcomes of intravenous Iron therapy in patients with heart failure and Iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials.
    J Cardiol. 2023 Jun 26:S0914-5087(23)00157-0. doi: 10.1016/j.jjcc.2023.
    >> Share

  94. GUDENKAUF B, Shaya G, Mukherjee M, Michos ED, et al
    Insulin resistance is associated with subclinical myocardial dysfunction and reduced functional capacity in heart failure with preserved ejection fraction.
    J Cardiol. 2023 Jun 24:S0914-5087(23)00153-3. doi: 10.1016/j.jjcc.2023.
    >> Share

  95. HUANG HT, Ko SL, Wang CY, Lo HC, et al
    Risk stratification for worsening renal function and renal decline in heart failure patients with reduced ejection fraction after sacubitril/valsartan treatment.
    J Cardiol. 2023 Jun 7:S0914-5087(23)00129-6. doi: 10.1016/j.jjcc.2023.
    >> Share

    May 2023
  96. NOGI K, Yamamoto R, Ueda T, Nogi M, et al
    Derivation and validation of a clinical predictive model of NT-proBNP >/=125 pg/mL to detect pre-heart failure.
    J Cardiol. 2023 May 27:S0914-5087(23)00126-0. doi: 10.1016/j.jjcc.2023.
    >> Share

  97. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    >> Share

  98. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    >> Share

  99. SHIBASAKI I, Otani N, Saito S, Ogawa H, et al
    Overview of mechanical circulatory support for the management of post-myocardial infarction ventricular septal rupture.
    J Cardiol. 2023;81:491-497.
    >> Share

    April 2023
  100. TAMAKI Y, Iwano H, Murayama M, Ishizaka S, et al
    Application of an echocardiographic scoring system of left ventricular filling pressure to diagnose acute heart failure in patients complaining dyspnea.
    J Cardiol. 2023 Apr 28:S0914-5087(23)00100-4. doi: 10.1016/j.jjcc.2023.
    >> Share

  101. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    >> Share

  102. JOKI Y, Konishi H, Takasu K, Minamino T, et al
    Tofogliflozin, a sodium-glucose cotransporter 2 inhibitor, improves pulmonary vascular remodeling due to left heart disease in mice.
    J Cardiol. 2023;81:347-355.
    >> Share

  103. SHINKAWA T, Ichihara Y, Saito S, Ishido M, et al
    Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    J Cardiol. 2023;81:378-384.
    >> Share

    March 2023
  104. KINOSHITA M, Saito M, Inoue K, Nakagawa H, et al
    Role of the right ventricular contractile reserve during low-load exercise in predicting heart failure readmission.
    J Cardiol. 2023 Mar 8:S0914-5087(23)00049-7. doi: 10.1016/j.jjcc.2023.
    >> Share

    February 2023
  105. MISUMI K, Matsue Y, Nogi K, Fujimoto Y, et al
    Derivation and validation of a machine learning-based risk prediction model in patients with acute heart failure.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00045-X. doi: 10.1016/j.jjcc.2023.
    >> Share

  106. TSUTSUI H, Sakamaki H, Momomura SI, Sakata Y, et al
    Cost-effectiveness analysis of Empagliflozin in patients with heart failure with reduced ejection fraction in Japan based on the EMPEROR-reduced trial.
    J Cardiol. 2023 Feb 27:S0914-5087(23)00046-1. doi: 10.1016/j.jjcc.2023.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016